BS19 Phosphodiesterase 1 (PDE1) inhibition enhances prostacyclin mediated signalling in pulmonary artery smooth muscle cells through a novel selective pde1c:prostacyclin receptor interaction

Zaher Al Bakour; James Hislop; James Guy Breitenbucher; Fiona Murray

doi:10.1136/heartjnl-2021-BCS.217

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Browse by collection

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Basic science

BS19 Phosphodiesterase 1 (PDE1) inhibition enhances prostacyclin mediated signalling in pulmonary artery smooth muscle cells through a novel selective pde1c:prostacyclin receptor interaction

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Al Bakour Z, Hislop J, Breitenbucher JG, et al

BS19 Phosphodiesterase 1 (PDE1) inhibition enhances prostacyclin mediated signalling in pulmonary artery smooth muscle cells through a novel selective pde1c:prostacyclin receptor interaction

Heart 2021;107:A167.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password